Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report)’s stock price gapped up prior to trading on Wednesday . The stock had previously closed at $6.87, but opened at $7.10. Aveanna Healthcare shares last traded at $6.9050, with a volume of 583,354 shares traded.
Analyst Ratings Changes
A number of research firms have recently issued reports on AVAH. BMO Capital Markets dropped their price target on Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating on the stock in a research note on Friday, March 20th. Truist Financial raised their target price on Aveanna Healthcare from $8.00 to $9.00 and gave the stock a “hold” rating in a research report on Wednesday, May 20th. Royal Bank Of Canada upgraded Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 price target for the company in a research note on Wednesday, June 3rd. Weiss Ratings cut shares of Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, April 6th. Finally, Barclays dropped their price objective on shares of Aveanna Healthcare from $9.50 to $9.00 and set an “overweight” rating on the stock in a report on Monday, May 18th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $10.50.
Check Out Our Latest Stock Report on Aveanna Healthcare
Aveanna Healthcare Stock Up 0.1%
Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) last issued its quarterly earnings results on Thursday, May 14th. The company reported $0.18 EPS for the quarter, topping analysts’ consensus estimates of $0.13 by $0.05. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.The business had revenue of $647.92 million during the quarter, compared to analysts’ expectations of $613.22 million. The company’s revenue was up 15.9% on a year-over-year basis. Sell-side analysts anticipate that Aveanna Healthcare Holdings Inc. will post 0.6 earnings per share for the current fiscal year.
Insider Activity
In other news, insider Patrick A. Cunningham sold 125,000 shares of the firm’s stock in a transaction on Wednesday, May 20th. The shares were sold at an average price of $7.59, for a total transaction of $948,750.00. Following the sale, the insider directly owned 212,755 shares in the company, valued at $1,614,810.45. This trade represents a 37.01% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, major shareholder J.H. Whitney Equity Partners V sold 5,842,240 shares of Aveanna Healthcare stock in a transaction on Wednesday, June 3rd. The shares were sold at an average price of $6.24, for a total transaction of $36,455,577.60. Following the transaction, the insider owned 13,450,547 shares in the company, valued at approximately $83,931,413.28. This trade represents a 30.28% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 19,967,240 shares of company stock worth $124,764,328 in the last quarter. 5.30% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Aveanna Healthcare
A number of institutional investors and hedge funds have recently bought and sold shares of the business. Caitong International Asset Management Co. Ltd boosted its stake in shares of Aveanna Healthcare by 252.4% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after acquiring an additional 2,400 shares during the period. Quantbot Technologies LP purchased a new position in Aveanna Healthcare in the 2nd quarter worth approximately $43,000. Summit Securities Group LLC purchased a new position in Aveanna Healthcare in the 1st quarter worth approximately $53,000. Oxford Asset Management LLP bought a new position in Aveanna Healthcare in the 2nd quarter worth approximately $64,000. Finally, Bayesian Capital Management LP purchased a new stake in Aveanna Healthcare during the 2nd quarter valued at approximately $85,000. 87.96% of the stock is owned by institutional investors.
Aveanna Healthcare Company Profile
Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.
In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.
Featured Stories
- Five stocks we like better than Aveanna Healthcare
- Chewy’s Growth Engine Is Stronger Than the Market Thinks
- Nebius Group’s £1.7 Billion UK Expansion Fuels Bullish Case Despite the Pullback
- An Analyst Just Raised Tesla’s Price Target by 227%—Here’s Why
- AST SpaceMobile’s SpaceX Catalyst Could Come With a Volatility Warning
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
